Priollet P
Service d'Hypertension, Hôpital Saint-Joseph, Paris.
J Mal Vasc. 1994;19 Suppl A:44-7.
Thromboses of the subclavian vein are rare. However there is a higher incidence due to the increasing use of central venous catheters and pacemakers. Thoracic outlet syndrome is no longer the main cause. Thromboses may be clinically apparent, however when they are caused by the insertion of a catheter, thromboses may be symptom-free. Phlebography is the gold standard for the diagnosis. B mode ultra-sounds may give false results in that particular location. The optimum treatment of subclavian thromboses should prevent the occurrence of pulmonary embolisms, and the development of post-thrombotic syndrome. Heparin followed by anti-vitamin K meets these two objectives in the majority of cases. The risks of thrombolytic therapy is, in our opinion, unacceptable to promote thrombolysis to treat upper limb venous thrombosis. Surgery is indicated in cases of phlematia caerulea which are extremely rare, and in cases of septic thrombosis. The preventive treatment of the opposite side of a symptomatic thoracic outlet syndrome, is questionable, except in the case where the findings of the clinical examination, B mode ultrasound and phlebography results, are in favor of a intermittent compression of the vein with a risk of thrombosis.
锁骨下静脉血栓形成较为罕见。然而,由于中心静脉导管和起搏器的使用日益增多,其发病率有所上升。胸廓出口综合征已不再是主要病因。血栓形成在临床上可能较为明显,但若是由导管插入引起的,血栓可能没有症状。静脉造影是诊断的金标准。B型超声在该特定部位可能会给出错误结果。锁骨下静脉血栓的最佳治疗应预防肺栓塞的发生以及血栓形成后综合征的发展。在大多数情况下,肝素继以抗维生素K能满足这两个目标。我们认为,溶栓治疗的风险对于促进上肢静脉血栓形成的溶栓治疗而言是不可接受的。在极为罕见的青紫性静脉炎病例以及脓毒性血栓形成的病例中,需要进行手术治疗。对于有症状的胸廓出口综合征对侧的预防性治疗存在疑问,除非临床检查、B型超声和静脉造影结果表明存在静脉间歇性受压并有血栓形成风险的情况。